Poster | 2023 ASCO Annual Meeting | Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.
Background: The onset of the COVID-19 pandemic resulted in major disruptions in enrollment and conduct of cancer clinical trials. In response, regulators allowed modifications to traditional trial processes to enable clinical research and care to continue. The American Society of Clinical Oncology and Friends of Cancer Research established a task force to evaluate how sponsors…
